The Impact of Hyperglycemia on Risk of Severe Infections during Early Period of Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

Table 3

Rates of severe infections between blood sugar groups during induction therapy (𝑛=155).

Blood sugar groups	Infection rates	𝑃 value	OR (95% CI)
<140 mg/dL	10.9% (10/91)		1 (reference)
140–200 mg/dL	15.9% (7/44)	0.422	1.532 (0.541–4.341)
≥200 mg/dL	55.0% (11/20)	<0.001	9.900 (3.299–29.709)